Clear Probiotics launched a probiotic formulated to reduce the risk of lip outbreaks and alleviate associated.
Photo © iStockphoto.com/Kurhan
Clear Probiotics (Boca Raton, FL) launched a probiotic formulated to reduce the risk of lip outbreaks and alleviate associated. The new product contains Lactobacillus Rhamnosus GG (LGG), one of the most clinically studied probiotics for digestive and immune health, Lactobacillus acidophilus, fructo-oligosaccharides, and Lysine.
“As someone who has suffered from lip outbreaks over the years, our mission with Clear Probiotics is to provide relief to the millions of men and women in our country who are also suffering from outbreaks,” said Greg Brauser, founder and CEO of Clear Probiotics, in a press release. “With our powerful formula containing a prebiotic and probiotic strains including LGG, Clear Probiotics will aid in preventing and alleviating outbreaks while strengthening the immune system and supporting overall health.”
According to the World Health Organization, 3.7 million people under the age of 50 (67%) have herpes simplex virus type 1 (HSV-1) globally. HSV-1 is associated with the symptom commonly known as cold sores. “The latest market industry research demonstrates the need for a probiotic such as Clear Probiotics for consumers who are seeking ways to prevent and alleviate lip outbreaks and have the disposable income to support their health and wellness,” added Brauser. “The industry is primed for growth and we are optimistic about the role Clear Probiotics will play in it.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.